SciClone Pharmaceuticals Inc (SCLN.OQ)

SCLN.OQ on NASDAQ Stock Exchange Global Select Market

8.63USD
17 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$8.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
205,934
52-wk High
$9.00
52-wk Low
$4.25

SCLN.OQ

Chart for SCLN.OQ

About

SciClone Pharmaceuticals, Inc. (SciClone) is a specialty pharmaceutical company. The Company has a product portfolio of therapies for oncology, infectious diseases, cardiovascular, urological, respiratory and central nervous system disorders. The Company’s main product is ZADAXIN (thymalfasin), which is approved in over 30... (more)

Overall

Beta: 2.12
Market Cap (Mil.): $438.18
Shares Outstanding (Mil.): 50.77
Dividend: --
Yield (%): --

Financials

  SCLN.OQ Industry Sector
P/E (TTM): 20.84 36.60 37.24
EPS (TTM): 0.41 -- --
ROI: 14.10 18.95 18.21
ROE: 14.10 19.73 19.11
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $105.54 +1.47
Novartis AG (NOVN.VX) CHF92.20 +3.25
Pfizer Inc. (PFE.N) $31.72 +0.60
Merck & Co., Inc. (MRK.N) $58.60 +0.97
Amgen, Inc. (AMGN.OQ) $166.69 +3.21
Gilead Sciences, Inc. (GILD.OQ) $104.80 +2.40

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks